Senior Electrical Engineer
For nearly 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work e perform. In return, we’ll help you build a career that you can feel passionate about.
We are seeking an experienced Senior Electrical Engineer for our Microbial Solutions site located in Charleston, South Carolina.
Summary of Position:
The Senior Electrical Engineer work on key Product Development/Engineering projects within Microbial Solutions, focusing on the electrical and system designs of current and new products. This role involves the development and creation of instrumentation that our customers use for endotoxin testing and microbial detection and identification. Responsibilities include electrical design, schematic creation, working with board designers on PCB layout, analog/digital interfaces, sensor control, and FPGA/micro controller development. This person will also interact with the other engineering disciplines (mechanical/software/system and production test).
- Bachelor degree or equivalent in Electrical Engineering, Software Engineering, Physics, or related field. An advanced degree is preferred.
- 10+ years related experience, preferably in biopharma, medical devices, aerospace or related industry
- Demonstrated skills in scientific and engineering methodologies, design of experiment skills in solving complex systems optimization problems and basic optical systems design.
- Previous experience in the design and development of visual optical, optoelectronic, and opto-mechanical systems,
- Experience in embedded designs, firmware, FPGA and software development
- Preferred: Demonstrated experience in design of system-based solutions of optical based products, which requires a multi-disciplined approach, involving a combination of software, electrical, optical and chemistry-biological technical expertise
About Microbial Solutions
Our Microbial Solutions business group has a comprehensive portfolio of endotoxin testing, microbial detection and microbial identification products and services is unlike any other, and has been purposefully designed to meet the complex and ever-changing needs of the industry. We help clients to ensure product safety and quality with easy-to-use yet robust testing solutions that satisfy regulatory requirements, support critical decision making and improve operational efficiencies.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.